Expression of Concern: The antidiabetic β3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin (Am J Clin Nutr 1992;55:237S-41S)
- PMID: 39632004
- DOI: 10.1016/j.ajcnut.2024.10.008
Expression of Concern: The antidiabetic β3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin (Am J Clin Nutr 1992;55:237S-41S)
Expression of concern for
-
The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin.Am J Clin Nutr. 1992 Jan;55(1 Suppl):237S-241S. doi: 10.1093/ajcn/55.1.237s. Am J Clin Nutr. 1992. PMID: 1345886
References
Publication types
LinkOut - more resources
Full Text Sources
